Latest News & Features
Big Pharma
UN-backed public health organisation The Medicine Patent Pool (MPP) has entered into a licence agreement with Merck Sharp & Dohme (MSD) and others to increase access to molnupiravir (MK-4482, EIDD-2801)—an investigational oral COVID-19 medicine—for low-and-middle-income countries (LMIC). 28 October 2021
Americas
Azurity Pharmaceuticals has sued Florida-based generic manufacturer CoreRx for infringing a pair of patents covering a hypertension drug for children. 28 October 2021
article
The US Patent Trial and Appeal Board (PTAB) has granted a review of a Novartis syringe patent following a challenge from biotech giant Regeneron. 28 October 2021
Medtech
Boston Scientific (BSC) and Nevro will testify before a Delaware Federal Court today following pleas from Nevro to delay the trial due to claims that BSC destroyed evidence related to a patent damages case. 26 October 2021
Americas
St Jude Medical will be able to claw back some of the attorney fees and expenses it incurred defending a suit filed by Niazi Licensing Corporation in a dispute over a patent covering a heart catheter. 26 October 2021
Americas
Bausch & Lomb has accused a Nashville-based ophthalmic company of infringing two patents covering its eye-brightening drops, Lumify. 26 October 2021
Big Pharma
Eli Lilly will have to pay undetermined royalties from the net sale of its diabetes treatment to Research Corporation Technologies, an Arizona judge has ruled. 21 October 2021
Americas
Law firm Kilpatrick Townsend & Stockton has announced the addition of Stuart Pollack to the firm’s New York office as a partner on the patent litigation team. 21 October 2021
Asia
Pfizer is seeking to block a generic version of its cancer drug Ibrance from entering the market until the patent covering the drug expires in May 2036. 21 October 2021
article
Foley & Lardner has hired a team of four former Maschoff Brennan attorneys to run a new IP litigation office in Salt Lake City. 21 October 2021